Clinical Trial Update: Topical 5% Imiquimod Cream for Vulvar Paget's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on topical 5% imiquimod cream for extramammary Paget's disease (vulvar Paget's disease).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paget Disease Extramammary

Drugs mentioned

• Imiquimod 5% cream (Imiquimod)

Snippet

Sponsor: University Medical Center Nijmegen | Conditions: Paget Disease, Extramammary | Phase 3 | Status: COMPLETED